Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-26T03:20:42.889Z Has data issue: false hasContentIssue false
  • English
  • Français

Prolonged Sleep Treatment in Mental Disorders (Some New Psychopharmacological Considerations)

Published online by Cambridge University Press:  08 February 2018

H. Azima
Get access Rights & Permissions [Opens in a new window]

Extract

Sleep as a method of controlling mental derangements dates to antiquity. According to Celsus sleep restores mental equilibrium: “but certainly for all so affected sleep is both difficult and especially necessary; for under it many get well …” (13). Griesinger in 1861 was the first to use chloroform as a sleep-inducing agent in mania and melancholia (21). The advent of bromides and barbiturates enhanced further investigation, and early in this century sleep treatment was relatively well systematized by Wolfin 1901 (40), Trend in 1903 (39), and by Kläsi in 1922 (25). This paper will not attempt to review the literature on sleep, for these findings have been outlined in papers by Palmer (32, 33), Baer (7), Ey (18), and recently in a documented book by Angel (2). The purpose of this paper is to present (1) a method of prolonged sleep treatment using the new inhibitory substance chlorpromazine (Largactil), in combination with different barbiturates in an attempt to provoke a sleep pattern as similar as possible to normal sleep, in contrast to deep unconsciousness advocated previously (14, 32); (2) to discuss underlying theories of sleep treatment, and propose some new formulations; (3) to suggest future use and investigation of the treatment; and (4) to bring to the attention of American psychiatrists a treatment which holds an eminent position in Europe, particularly in the U.S.S.R. where sleep therapy appears to be the only officially accepted form of treatment in mental illnesses.

Type
Original Articles
Information
Journal of Mental Science , Volume 101 , Issue 424 , July 1955 , pp. 593 - 603
Copyright
Copyright © Royal College of Psychiatrists, 1955 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andreef, , “Conference concerning Psychosomatic Problems: Director Bikov, Jan., 1948, Leningrad”; Publication of U.S.S.R. Academy of Med. Science, 1949, Moscow. (Quoted by Brisset and Gakel.) Google Scholar
Angel, J. M., La thérapeutique par le sommeil, 1953. Paris: Masson and Cie.Google Scholar
Angyal, A., Foundations for a Science of Personality, 1941. New York: Commonwealth Fund.Google Scholar
Azima, H., “Fundamentals of a Neo-Jacksonian Conception of Psychiatry and Neurology, H. Ey's ‘Organo-Dynamism'”, Arg. Neuro-Psychiat., 1953, 11, 360–370.Google Scholar
Azima, H., and Ogle, W., “Effects of Largactil in mental syndromes”, Can. Med. Ass. J., 1954, 71, 116–121.Google Scholar
Azima, H., Cramer, Fern J., and Faure, H., “Système reticulé activateur central; son rôle en psychopathologie”, Evol. Psychiat., 1955, 121–145.Google Scholar
Baer, H., “Die Schlafkur”, Schweiz. Arch. fur Neurol. u. Psychiat., 1949, 64, 17–54.Google Scholar
Bird, B., “Pathological sleep”, Internat. J. Psychoanal., 1954, 35, 20–29.Google Scholar
Boss, M., “Die Psychische Dynamik der Schlafkur bei Schizophrenen”, Schweiz. Arch. f. Neurol. u. Psychiat., 1935, 36, 209–220.Google Scholar
Brisset, C., and Gakel, V., “La médicine psychosomatique en U.S.S.R. 1 : la cure de sommeil”, Press Méd., 1951, 59, 465–466.Google Scholar
Cameron, D. E., “Psychic Driving”, Am. J. Psychiat. (in press). Google Scholar
Idem , Personal communications.Google Scholar
Celsus, De Medicina. Trans. by Spencer, W. G. Loeb Classical Library. 1935–38. London: Wm. Heinemann.Google Scholar
Clapp, J. S., and Loomis, E. A., “Continuous sleep treatment”, Am. J. Psychiat., 1950, 106, 821–829.Google Scholar
Davtoenkov, , “Thérapeutique par le sommeil artificiel prolongé”, Médecine et hygiène, 1951, 9, 204–209.Google Scholar
Delay, J., Deniker, P., and Harl, J. M., “Utilisation en thérapeutique psychiatrique d'une phénothiazine d'action centrale elective (4560 R.P.)”, Ann. Medico-Psychol., 1952 110, 112–117.Google Scholar
Ey, H., Études Psychiatriques, 1948. Paris: Deselee de Brouwer et Cie.Google Scholar
Idem and Berard, E., “Les nouvelles techniques de cure de sommeil dans la pratique psychiatrique”, Evol. Psychiat., 1952, 4, 661–682.Google Scholar
French, J. D., Verzeano, M., and Magoun, H. W., “An extralemniscal sensory system in the brain”, Arch. Neurol. Psychiat., 1953, 69, 505–518.Google Scholar
Furrer, J., “Unsere Erfahrungen mit den Somnifendauernarkosen bei Psychosen”, Schweiz. med. Wochensch., 1924, 54, 275–280.Google Scholar
Griesinger, W., Mental pathology and Therapeutics. Trans. by Robertson, and Rutherford, , 1882. Wm. Wood and Co.Google Scholar
Heldt, F. J., “The therapeutic use of prolonged sodium amytal narcosis”, Am. J. Psychiat., 1947, 104, 27–35.Google Scholar
Hess, W. R., “Uber die Wechselbeziehungen zwischen psychiatrischen und vegetativen Funktionen”, Schweiz. Arch. fur Neurol. u. Psychiat., 1924, 15, 260–377.Google Scholar
Hiebel, G., Bonvallet, M., and Dell, P., “Action de la chlorpromazine (Largactil, 4560 R.P.) au niveau système nerveux central”, Sem. Hop., 30em année, 37, 2346.Google Scholar
Kläsi, J., “Uber die therapeutische Anwendung des Dauernarkose mittels Somnifens bei Schizophrenen”, Zeitsch. f. d. ges. Neurol. u. Psychiat., 1922, 74, 557–592.Google Scholar
Kubie, L., “Some implications for psychoanalysis of modern concepts of the organization of the brain”, Psychoanal. Quart., 1953, 22, 21–68.Google Scholar
Lehmann, H. E., and Hanrahan, G. E., “Chlorpromazine: new agent for psychomotor excitement and manic states”, Arch. Neurol. Psychiat., 1954, 71, 227–237.Google Scholar
Magoun, H. W., “Ascending Reticular Activating System”, Biology of Mental Health and Disease, 1952, pp. 219–224. P. B. Hoeber.Google Scholar
Margolin, S. G., “Psychotherapeutic principles in psychosomatic practice”, in Wittkower and Cleghorn's Recent Developments in Psychosomatic Medicine, 1954, pp. 134–156. London: Sir Isaac Pitman and Sons, Ltd.Google Scholar
Monnier, M., “Die Dauerschlafbehandlungen des Schizophrenienen mit der Narkosenmischung von Cloetta an der Psychiatrischen Klinik Burghölzli-Zürich”, Nervenarzt, 1936, 9, 14–29.Google Scholar
Muller, M., “Die Dauernarkose mit flüssigem Dial bei Psychosen, speziell bei manishdepressiven Irresein”, Zeitschr. f. d. ges. Neurol. u. Psychiat., 1927, 107, 522–542.Google Scholar
Palmer, H. A., “The value of continuous narcosis in the treatment of mental disorders”, J. ment. Sci., 1937, 83, 636–678.CrossRefGoogle Scholar
Idem and Braceland, F. J., “Six years experience with narcosis therapy in psychiatry”, Am. J. Psychiat., 1937, 94, 37–53.Google Scholar
Scott, W. C. M., “Patients who sleep or look at the psychoanalyst during treatment—technical considerations”, Int. J. Psychoanal., 1952, 33, 465–469.Google Scholar
Shagass, C., Personal communications.Google Scholar
Idem , “Clinical significance of the photoclonic response in psychiatric patients”, E.E.G. and Clin. Neurophysiol., 1954, 6, 445–453.CrossRefGoogle Scholar
Simmel, E., “Neurotic disturbances of sleep”, Int. J. Psychoanal., 1942, 23, 65–68.Google Scholar
Stasie, C., Azima, H., Hauffman, M., and Howlett, J. A., “Jaundice occurring during the administration of Chlorpromazine”, Canad. Med. Ass. J. (In Press).Google Scholar
Trenel, , Rapport au congrès des aliénistes français sur le traitement des états d'agitation et d'insomnie, 1903.Google Scholar
Wolf, H., “Trionalkur”, Centralblatt für Nervenheilkunde, 1901, 286–283 and 545–547. Google Scholar
Wortis, J., Soviet Psychiatry, 1950, pp. 161–165. Williams and Wilkins Co. Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.